248
Participants
Start Date
July 22, 2020
Primary Completion Date
March 31, 2026
Study Completion Date
March 31, 2026
Dazostinag
Dazostinag intravenous infusion.
Pembrolizumab
Pembrolizumab intravenous infusion.
Platinum
Carboplatin or Cisplatin intravenous infusion
5-fluorouracil
5-fluorouracil intravenous infusion
Centre Hospitalier Universitaire Vaudois Lausanne, Lausanne
Hopitaux Universitaires de Geneve, Geneva
Inselspital Universitatsspital Bern, Bern
Klinikum Wels-Grieskirchen, Wels
Kantonsspital Sankt Gallen, Sankt Gallen
Hopital de la Timone, Marseille
University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh
Fox Chase Cancer Center, Philadelphia
Centre Georges Francois Leclerc, Dijon
University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore
Centre Hospitalier Regional et Universitaire de Besancon - Hopital Jean-Minjoz, Besançon
Memorial Cancer Institute at Memorial Hospital West - Cancer Institute/Radiology Oncology, Gainesville
Hopital Saint-Andre, Bordeaux
Sarah Cannon Research Institute (SCRI), Nashville
Institut de Cancerologie de lOuest - Saint-Herblain - Site Rene Gauducheau, Saint-Herblain
University of Cincinnati Health Barrett Cancer Center, Cincinnati
West Chester Hospital, West Chester
Barbara Ann Karmanos Cancer Institute - Lawrence and Idell Weisberg Cancer Treatment Center, Detroit
The Chaim Sheba Medical Center, Tel Litwinsky
Centre de Lutte contre le Cancer - Centre Oscar Lambret, Lille
Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
Siteman Cancer Center - North County, Florissant
Siteman Cancer Center - South County, St Louis
Siteman Cancer Center - West County, Creve Coeur
Siteman Cancer Center - St. Peters, City of Saint Peters
Tel Aviv Sourasky Medical Center, Tel Aviv
Centre Leon Berard, Lyon
Hopital Saint-Antoine, Paris
Mary Crowley Cancer Research, Dallas
University of California San Diego Moores Cancer Center, La Jolla
Hopital Foch, Suresnes
UCI Health - Chao Family Comprehensive Cancer Center, Orange
Gustave Roussy, Villejuif
Providence Portland Medical Center, Portland
Beijing Cancer Hospital, Beijing
Fudan University Shanghai Cancer Center, Shanghai
Shanghai East Hospital, Shanghai
Zhejiang Cancer Hospital, Hangzhou
Sixth Affiliated Hospital of Sun Yat-Sen University/Guangdong Gastrointestinal Hospital, Guangzhou
West China Hospital, Chengdu
West China School of Medicine - West China Hospital of Sichuan University, Chengdu
Hadassah University Hospital Ein Kerem, Jerusalem
Soroka Medical Center, Beersheba
Norris Comprehensive Cancer Center, Los Angeles
University of California Los Angeles - Jonsson Comprehensive Cancer Center, Santa Monica
SCRI - HealthOne Denver, Denver
Yale Cancer Center, New Haven
Massachusetts General Hospital, Boston
Dana-Farber Cancer Institute, Boston
Washington University School of Medicine Siteman Cancer Center, St Louis
University of Cincinnati Health Barrett Cancer Center, Cincinnati
Virginia Cancer Specialists, P.C. - Fairfax, Fairfax
Princess Margaret Cancer Centre, Toronto
Jewish General Hospital, Montreal
McGill University Health Centre, Montreal
National Cancer Center Hospital, Chuo-Ku
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy, Warsaw
PanOncology Trials: Universidad de Puerto Rico - Centro Comprensivo de Cancer, San Juan
Queen's University Belfast, Belfast
Leeds Teaching Hospitals NHS Trust, Leeds
University College London Hospitals NHS Foundation Trust, London
Oxford University Hospitals NHS Foundation Trust, Oxford
Lead Sponsor
Takeda
INDUSTRY